Regulation and function of proinflammatory TH17 cells

Annals of the New York Academy of Sciences

Volumn 1143, Issue , 2008, Pages 188-211

  Martinez, Gustavo J ^a   Nurieva, Roza I ^a   Yang, Xuexian O ^a   Dong, Chen ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Antigen presenting cells; CD4+ T helper; Pro inflammatory TH17 cells

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CYTOKINE; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 1; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 27; INTERLEUKIN 4; INTERLEUKIN 6; RETINOIC ACID RECEPTOR GAMMA; STAT PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA;

ARTHRITIS; CELL ACTIVATION; CELL DIFFERENTIATION; CELL LINEAGE; ENTERITIS; FUNGAL CELL; HELPER CELL; HUMAN; IMMUNE RESPONSE; MEMORY T LYMPHOCYTE; MULTIPLE SCLEROSIS; MYCOBACTERIUM TUBERCULOSIS; MYCOPLASMA PNEUMONIAE; PHENOTYPE; PSORIASIS; REVIEW;

EID: 56549110910     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1443.021     Document Type: Review

References (178)

1. Dong, C. & R.A. Flavell. 2000. Cell fate decision: T-helper 1 and 2 subsets in immune responses. Arthritis Res. 2 : 179 188.
2. Infante-Duarte, C. et al. 2000. Microbial lipopeptides induce the production of IL-17 in Th cells. J. Immunol. 165 : 6107 6115.
3. Aggarwal, S. et al. 2003. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278 : 1910 1914.
4. Bettelli, E. et al. 2004. Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis. J. Exp. Med. 200 : 79 87.
5. Ferber, I.A. et al. 1996. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156 : 5 7.
6. Kageyama, Y. et al. 1998. Reduced susceptibility to collagen-induced arthritis in mice deficient in IFN-gamma receptor. J. Immunol. 161 : 1542 1548.
7. Willenborg, D.O. et al. 1996. IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157 : 3223 3227.
8. Dong, C. & R.I. Nurieva. 2003. Regulation of immune and autoimmune responses by ICOS. J. Autoimmun. 21 : 255 260.
9. Murphy, C.A. et al. 2003. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198 : 1951 1957.
10. Langrish, C.L. et al. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201 : 233 240.
11. Park, H. et al. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6 : 1133 1141.
12. Harrington, L.E. et al. 2005. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6 : 1123 1132.
13. Dong, C. 2008. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat. Rev. Immunol. 8 : 337 348.
14. Bettelli, E. et al. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441 : 235 238.
15. Veldhoen, M. et al. 2006. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24 : 179 189.
16. Mangan, P.R. et al. 2006. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441 : 231 234.
17. Gorelik, L. & R.A. Flavell. 2002. Transforming growth factor-beta in T-cell biology. Nat. Rev. Immunol. 2 : 46 53.
18. Chen, W. et al. 2003. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198 : 1875 1886.
19. Zhou, L. et al. 2008. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 453 : 236 240.
20. Li, M.O., Y.Y. Wan & R.A. Flavell. 2007. T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 26 : 579 591.
21. Korn, T. et al. 2007. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448 : 484 487.
22. Yang, X.O. et al. 2007. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J. Biol. Chem. 282 : 9358 9363.
23. Elias, K.M. et al. 2008. Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood 111 : 1013 1020.
24. Mucida, D. et al. 2007. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317 : 256 260.
25. Schambach, F. et al. 2007. Activation of retinoic acid receptor-alpha favours regulatory T cell induction at the expense of IL-17-secreting T helper cell differentiation. Eur. J. Immunol. 37 : 2396 2399.
26. Kang, S.G. et al. 2007. Vitamin A metabolites induce gut-homing FoxP3+ regulatory T cells. J. Immunol. 179 : 3724 3733.
27. Sun, C.M. et al. 2007. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204 : 1775 1785.
28. Coombes, J.L. et al. 2007. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 204 : 1757 1764.
29. Nurieva, R. et al. 2007. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448 : 480 483.
30. Zhou, L. et al. 2007. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8 : 967 974.
31. Oppmann, B. et al. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13 : 715 725.
32. Parham, C. et al. 2002. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 168 : 5699 5708.
33. Cua, D.J. et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421 : 744 748.
34. Yen, D. et al. 2006. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 116 : 1310 1316.
35. Moller, B. & P.M. Villiger. 2006. Inhibition of IL-1, IL-6, and TNF-alpha in immune-mediated inflammatory diseases. Springer Semin Immunopathol. 27 : 391 408.
36. Arend, W.P. 2002. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev. 13 : 323 340.
37. Braddock, M. & A. Quinn. 2004. Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention. Nat. Rev. Drug Discov. 3 : 330 339.
38. Schiffenbauer, J. et al. 2000. The induction of EAE is only partially dependent on TNF receptor signaling but requires the IL-1 type I receptor. Clin. Immunol. 95 : 117 123.
39. Sutton, C. et al. 2006. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 203 : 1685 1691.
40. Kryczek, I. et al. 2007. Cutting edge: opposite effects of IL-1 and IL-2 on the regulation of IL-17+ T cell pool IL-1 subverts IL-2-mediated suppression. J. Immunol. 179 : 1423 1426.
41. Felderhoff-Mueser, U. et al. 2005. IL-18: a key player in neuroinflammation and neurodegeneration? Trends Neurosci. 28 : 487 493.
42. Wildbaum, G. et al. 1998. Neutralizing antibodies to IFN-gamma-inducing factor prevent experimental autoimmune encephalomyelitis. J. Immunol. 161 : 6368 6374.
43. Shi, F.D. et al. 2000. IL-18 directs autoreactive T cells and promotes autodestruction in the central nervous system via induction of IFN-gamma by NK cells. J. Immunol. 165 : 3099 3104.
44. Gutcher, I. et al. 2006. Interleukin 18-independent engagement of interleukin 18 receptor-alpha is required for autoimmune inflammation. Nat. Immunol. 7 : 946 953.
45. Mathur, A.N. et al. 2007. Stat3 and Stat4 direct development of IL-17-secreting Th cells. J. Immunol. 178 : 4901 4907.
46. Kang, Y.J. et al. 2005. Involvement of TL1 A and DR3 in induction of pro-inflammatory cytokines and matrix metalloproteinase-9 in atherogenesis. Cytokine 29 : 229 235.
47. Bamias, G. et al. 2003. Expression, localization, and functional activity of TL1 A, a novel Th1-polarizing cytokine in inflammatory bowel disease. J. Immunol. 171 : 4868 4874.
48. Prehn, J.L. et al. 2004. Potential role for TL1 A, the new TNF-family member and potent costimulator of IFN-gamma, in mucosal inflammation. Clin. Immunol. 112 : 66 77.
49. Prehn, J.L. et al. 2007. The T cell costimulator TL1 A is induced by FcgammaR signaling in human monocytes and dendritic cells. J. Immunol. 178 : 4033 4038.
50. Al-Lamki, R.S. et al. 2003. Expression of silencer of death domains and death-receptor-3 in normal human kidney and in rejecting renal transplants. Am. J. Pathol. 163 : 401 411.
51. Wang, E.C. et al. 2001. Genomic structure, expression, and chromosome mapping of the mouse homologue for the WSL-1 (DR3, Apo3, TRAMP, LARD, TR3, TNFRSF12) gene. Immunogenetics 53 : 59 63.
52. Pappu, B.P. et al. 2008. TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease. J. Exp. Med. 205 : 1049 1062.
53. Iwakura, Y. & H. Ishigame. 2006. The IL-23/IL-17 axis in inflammation. J. Clin. Invest. 116 : 1218 1222.
54. McKenzie, B.S., R.A. Kastelein & D.J. Cua. 2006. Understanding the IL-23-IL-17 immune pathway. Trends Immunol 27 : 17 23.
55. Hunter, C.A. 2005. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol. 5 : 521 531.
56. Batten, M. & N. Ghilardi. 2007. The biology and therapeutic potential of interleukin 27. J. Mol. Med. 85 : 661 672.
57. Owaki, T. et al. 2006. IL-27 suppresses CD28-mediated [correction of medicated] IL-2 production through suppressor of cytokine signaling 3. J. Immunol. 176 : 2773 2780.
58. Villarino, A.V. et al. 2006. IL-27 limits IL-2 production during Th1 differentiation. J. Immunol. 176 : 237 247.
59. Batten, M. et al. 2006. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 7 : 929 936.
60. Stumhofer, J.S. et al. 2006. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 7 : 937 945.
61. Batten, M. et al. 2008. Cutting Edge: IL-27 Is a Potent Inducer of IL-10 but Not FoxP3 in Murine T Cells. J. Immunol. 180 : 2752 2756.
62. Fitzgerald, D.C. et al. 2007. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat. Immunol. 8 : 1372 1379.
63. Laurence, A. et al. 2007. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26 : 371 381.
64. Amadi-Obi, A. et al. 2007. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat. Med. 13 : 711 718.
65. Chen, Z. et al. 2006. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc. Natl. Acad. Sci. USA 103 : 8137 8142.
66. Ivanov, I.I. et al. 2006. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126 : 1121 1133.
67. Yang, X.O. et al. 2008. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 28 : 29 39.
68. Milner, J.D. et al. 2008. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452 : 773 776.
69. Jetten, A.M. 2004. Recent advances in the mechanisms of action and physiological functions of the retinoid-related orphan receptors (RORs). Curr. Drug Targets Inflamm. Allergy 3 : 395 412.
70. Hu, C.M. et al. 2002. Modulation of T cell cytokine production by interferon regulatory factor-4. J. Biol. Chem. 277 : 49238 49246.
71. Lohoff, M. et al. 2002. Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4. Proc. Natl. Acad. Sci. USA 99 : 11808 11812.
72. Rengarajan, J. et al. 2002. Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression. J. Exp. Med. 195 : 1003 1012.
73. Brustle, A. et al. 2007. The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat. Immunol. 8 : 958 966.
74. Schmidt, J.V. et al. 1996. Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. Proc. Natl. Acad. Sci. USA 93 : 6731 6736.
75. Veldhoen, M. et al. 2008. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453 : 106 109.
76. Quintana, F.J. et al. 2008. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 453 : 65 71.
77. Zenewicz, L.A. et al. 2007. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 27 : 647 659.
78. Derynck, R. & Y.E. Zhang. 2003. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425 : 577 584.
79. Yang, X.O. et al. 2008. Analysis of inflammatory and regulatory T cell lineage determination assisted with an IL-17F knockin reporter mouse. Immunity 29 : 44 56.
80. Du, J. et al. 2008. Isoform-specific inhibition of ROR{alpha)-mediated transcriptional activation by human FOXP3. J. Immunol. 180 : 4785 4792.
81. Rangachari, M. et al. 2006. T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J. Exp. Med. 203 : 2009 2019.
82. Moisan, J. et al. 2007. Ets-1 is a negative regulator of Th17 differentiation. J. Exp. Med. 204 : 2825 2835.
83. Acosta-Rodriguez, E.V. et al. 2007. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 8 : 639 646.
84. Sallusto, F., C.R. Mackay & A. Lanzavecchia. 2000. The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 18 : 593 620.
85. Lim, H.W. et al. 2008. Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells. J. Immunol. 180 : 122 129.
86. Sato, W., T. Aranami & T. Yamamura. 2007. Cutting edge: Human Th17 cells are identified as bearing CCR2+CCR5- phenotype. J. Immunol. 178 : 7525 7529.
87. Toscano, M.A. et al. 2007. Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat. Immunol. 8 : 825 834.
88. Nakae, S. et al. 2007. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J. Leukoc. Biol. 81 : 1258 1268.
89. Wilson, N.J. et al. 2007. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8 : 950 957.
90. Acosta-Rodriguez, E.V. et al. 2007. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8 : 942 949.
91. Annunziato, F. et al. 2007. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 204 : 1849 1861.
92. Chen, Z. et al. 2007. Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis Rheum. 56 : 2936 2946.
93. Volpe, E. et al. 2008. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat. Immunol. 9 : 650 657.
94. Manel, N., D. Unutmaz & D.R. Littman. 2008. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat. Immunol. 9 : 641 649.
95. Yang, L. et al. 2008. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 454 : 350 352.
96. Cooper, A.M. et al. 2002. Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present. J. Immunol. 168 : 1322 1327.
97. Happel, K.I. et al. 2005. Pulmonary interleukin-23 gene delivery increases local T-cell immunity and controls growth of Mycobacterium tuberculosis in the lungs. Infect. Immun. 73 : 5782 5788.
98. Khader, S.A. et al. 2005. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available. J. Immunol. 175 : 788 795.
99. Aujla, S.J. et al. 2008. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 14 : 275 281.
100. Khader, S.A. et al. 2007. IL-23 and IL-17 in the establishment of protective pulmonary CD4 +T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 8 : 369 377.
101. Umemura, M. et al. 2007. IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection. J. Immunol. 178 : 3786 3796.
102. Liang, S.C. et al. 2006. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203 : 2271 2279.
103. Chung, Y. et al. 2006. Expression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes. Cell Res. 16 : 902 907.
104. Scriba, T.J. et al. 2008. Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response. J. Immunol. 180 : 1962 1970.
105. Happel, K.I. et al. 2005. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J. Exp. Med. 202 : 761 769.
106. Happel, K.I. et al. 2003. Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J. Immunol. 170 : 4432 4436.
107. Ye, P. et al. 2001. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194 : 519 527.
108. Wu, Q. et al. 2007. IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection. Microbes. Infect. 9 : 78 86.
109. Caruso, R. et al. 2008. IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa. Eur. J. Immunol. 38 : 470 478.
110. Zheng, Y. et al. 2008. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14 : 282 289.
111. Patera, A.C. et al. 2002. Interleukin 17 modulates the immune response to vaccinia virus infection. Virology 299 : 56 63.
112. Maertzdorf, J., A.D. Osterhaus & G.M. Verjans. 2002. IL-17 expression in human herpetic stromal keratitis: modulatory effects on chemokine production by corneal fibroblasts. J. Immunol. 169 : 5897 5903.
113. Smiley, K.L. et al. 2007. Association of gamma interferon and interleukin-17 production in intestinal CD4+ T cells with protection against rotavirus shedding in mice intranasally immunized with VP6 and the adjuvant LT(R192G). J. Virol. 81 : 3740 3748.
114. Maek, A.N.W. et al. 2007. Increased interleukin-17 production both in helper T cell subset Th17 and CD4-negative T cells in human immunodeficiency virus infection. Viral Immunol. 20 : 66 75.
115. Misse, D. et al. 2007. IL-22 participates in an innate anti-HIV-1 host-resistance network through acute-phase protein induction. J. Immunol. 178 : 407 415.
116. Kim, B. et al. 2008. Enhanced viral immunoinflammatory lesions in mice lacking IL-23 responses. Microbes. Infect. 10 : 302 312.
117. Kelly, M.N. et al. 2005. Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infect. Immun. 73 : 617 621.
118. Rutitzky, L.I., J.R. Lopes da Rosa & M.J. Stadecker. 2005. Severe CD4 T cell-mediated immunopathology in murine schistosomiasis is dependent on IL-12p40 and correlates with high levels of IL-17. J. Immunol. 175 : 3920 3926.
119. Rutitzky, L.I. et al. 2008. IL-23 is required for the development of severe egg-induced immunopathology in schistosomiasis and for lesional expression of IL-17. J. Immunol. 180 : 2486 2495.
120. Rudner, X.L. et al. 2007. Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect. Immun. 75 : 3055 3061.
121. Kleinschek, M.A. et al. 2006. IL-23 enhances the inflammatory cell response in Cryptococcus neoformans infection and induces a cytokine pattern distinct from IL-12. J. Immunol. 176 : 1098 1106.
122. Zelante, T. et al. 2007. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur. J. Immunol. 37 : 2695 2706.
123. De Luca, A. et al. 2007. Functional yet balanced reactivity to Candida albicans requires TRIF, MyD88, and IDO-dependent inhibition of Rorc. J. Immunol. 179 : 5999 6008.
124. Bozza, S. et al. 2008. Lack of Toll IL-1R8 Exacerbates Th17 Cell Responses in Fungal Infection. J. Immunol. 180 : 4022 4031.
125. Coussens, L.M. & Z. Werb. 2002. Inflammation and cancer. Nature 420 : 860 867.
126. Numasaki, M. et al. 2005. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J. Immunol. 175 : 6177 6189.
127. Langowski, J.L. et al. 2006. IL-23 promotes tumour incidence and growth. Nature 442 : 461 465.
128. Benchetrit, F. et al. 2002. Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism. Blood 99 : 2114 2121.
129. Kottke, T. et al. 2007. Induction of hsp70-mediated Th17 autoimmunity can be exploited as immunotherapy for metastatic prostate cancer. Cancer Res. 67 : 11970 11979.
130. Muranski, P. et al. 2008. Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood. 112 : 362 373.
131. Segal, B.M., B.K. Dwyer & E.M. Shevach. 1998. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 187 : 537 546.
132. Thakker, P. et al. 2007. IL-23 is critical in the induction but not in the effector phase of experimental autoimmune encephalomyelitis. J. Immunol. 178 : 2589 2598.
133. Komiyama, Y. et al. 2006. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177 : 566 573.
134. Yang, X.O. et al. 2008. Regulation of inflammatory responses by IL-17F. J. Exp. Med. 205 : 1063 1075.
135. Kreymborg, K. et al. 2007. IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis. J. Immunol. 179 : 8098 8104.
136. Kebir, H. et al. 2007. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 13 : 1173 1175.
137. Tzartos, J.S. et al. 2008. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 172 : 146 155.
138. Carlson, T. et al. 2008. The Th17-ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease. J. Exp. Med. 205 : 811 823.
139. Stromnes, I.M. et al. 2008. Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat. Med. 14 : 337 342.
140. Nakae, S. et al. 2003. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 171 : 6173 6177.
141. Nakae, S. et al. 2003. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc. Natl. Acad. Sci. USA 100 : 5986 5990.
142. Lubberts, E. et al. 2004. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum. 50 : 650 659.
143. Ruddy, M.J. et al. 2004. Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment. J. Leukoc. Biol. 76 : 135 144.
144. Sato, K. et al. 2006. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 203 : 2673 2682.
145. Nakashima, T. & H. Takayanagi. 2008. The dynamic interplay between osteoclasts and the immune system. Arch. Biochem. Biophys. 473 : 166 171.
146. Hirota, K. et al. 2007. T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. J. Exp. Med. 204 : 41 47.
147. Hirota, K. et al. 2007. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J. Exp. Med. 204 : 2803 2812.
148. Agarwal, S., R. Misra & A. Aggarwal. 2008. Interleukin 17 levels are increased in juvenile idiopathic arthritis synovial fluid and induce synovial fibroblasts to produce proinflammatory cytokines and matrix metalloproteinases. J. Rheumatol. 35 : 515 519.
149. Nistala, K. et al. 2008. Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers. Arthritis Rheum. 58 : 875 887.
150. Kohno, M. et al. 2008. Interleukin-17 gene expression in patients with rheumatoid arthritis. Mod. Rheumatol. 18 : 15 22.
151. Joosten, L.A. et al. 2008. T cell dependence of chronic destructive murine arthritis induced by repeated local activation of Toll-like receptor-driven pathways: crucial role of both interleukin-1beta and interleukin-17. Arthritis Rheum. 58 : 98 108.
152. Li, D. et al. 2004. Expression of LL-37, human beta defensin-2, and CCR6 mRNA in patients with psoriasis vulgaris. J. Huazhong Univ. Sci. Technolog Med. Sci. 24 : 404 406.
153. Li, J., D. Li & Z. Tan. 2004. The expression of interleukin-17, interferon-gamma, and macrophage inflammatory protein-3 alpha mRNA in patients with psoriasis vulgaris. J. Huazhong Univ. Sci. Technolog Med. Sci. 24 : 294 296.
154. Piskin, G. et al. 2006. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. J. Immunol. 176 : 1908 1915.
155. Lee, E. et al. 2004. Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J. Exp. Med. 199 : 125 130.
156. Wolk, K. et al. 2006. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur. J. Immunol. 36 : 1309 1323.
157. Ma, H.L. et al. 2008. IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J. Clin. Invest. 118 : 597 607.
158. Zheng, Y. et al. 2007. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445 : 648 651.
159. Boniface, K. et al. 2007. A role for T cell-derived interleukin 22 in psoriatic skin inflammation. Clin. Exp. Immunol. 150 : 407 415.
160. Zaba, L.C. et al. 2007. Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J. Exp. Med. 204 : 3183 3194.
161. Lowes, M.A. et al. 2008. Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells. J. Invest. Dermatol. 128 : 1207 1211.
162. Krueger, G.G. et al. 2007. A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N. Engl. J. Med. 356 : 580 592.
163. Zhang, Z. et al. 2006. Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm. Bowel Dis. 12 : 382 388.
164. Monteleone, G. et al. 2006. Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21. Gut 55 : 1774 1780.
165. Caruso, R. et al. 2007. A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3alpha, by gut epithelial cells. Gastroenterology 132 : 166 175.
166. Monteleone, G. et al. 2005. Interleukin-21 enhances T-helper cell type I signaling and interferon-gamma production in Crohn's disease. Gastroenterology 128 : 687 694.
167. Fina, D. et al. 2008. Regulation of gut inflammation and th17 cell response by interleukin-21. Gastroenterology 134 : 1038 1048.
168. Schmechel, S. et al. 2008. Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL-22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status. Inflamm. Bowel Dis. 14 : 204 212.
169. Wolk, K. et al. 2007. IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn's disease. J. Immunol. 178 : 5973 5981.
170. Amre, D.K. et al. 2008. Association Between Genetic Variants in the IL-23R Gene and Early-Onset Crohn's Disease: Results From a Case-Control and Family-Based Study Among Canadian Children. Am. J. Gastroenterol. 103 : 615 620.
171. Capon, F. et al. 2007. Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Hum. Genet. 122 : 201 206.
172. Cargill, M. et al. 2007. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am. J. Hum. Genet. 80 : 273 290.
173. Smith, R.L. et al. 2008. Polymorphisms in the IL-12beta and IL-23R genes are associated with psoriasis of early onset in a UK cohort. J. Invest. Dermatol. 128 : 1325 1327.
174. Burton, P.R. et al. 2007. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat. Genet. 39 : 1329 1337.
175. Illes, Z. et al. 2008. 3′UTR C2370 A allele of the IL-23 receptor gene is associated with relapsing-remitting multiple sclerosis. Neurosci. Lett. 431 : 36 38.
176. Huber, A.K. et al. 2008. Interleukin (IL)-23 receptor is a major susceptibility gene for Graves' ophthalmopathy: the IL-23/T-helper 17 axis extends to thyroid autoimmunity. J. Clin. Endocrinol. Metab. 93 : 1077 1081.
177. Borgogni, E. et al. 2008. Elocalcitol inhibits inflammatory responses in human thyroid cells and T cells. Endocrinology 149 : 3626 3634.
178. Seiderer, J. et al. 2008. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): Upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17 F p.His161Arg polymorphism in IBD. Inflamm. Bowel Dis. 14 : 437 445.